The mechanism of matrix-synthesis and-degradation in vascular smooth muscle cells.
The mechanism of matrix-synthesis and-degradation in vascular smooth muscle cells.
批准号:
10670220
负责人:
KATO Seiya
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
为了解血管平滑肌细胞(SMC)表型调节与基质重塑过程的关系,建立了血管平滑肌细胞表型调节的体外培养模型。通过血清浓度和最终细胞密度的变化来验证培养条件。采用Western blotting和酶免疫法检测基质金属蛋白酶(MMPs)及其抑制剂(TIMPs)的表达。同时测定了胶解活性和凝胶解活性。MMP-1、TIMP-1-3和MMP-1rrIMP-1在增殖表型细胞中的表达和活性最高。MMP-2的表达不随SMC表型而改变。制备了表达TIMP-1的腺病毒载体,并利用该载体进行SMC表型或功能分析。胞外基质的数量也通过细胞周期调控基因的功能调节SMC表型。细胞周期蛋白依赖性激酶抑制剂p2lWaf-1在体外培养的SMC和人动脉粥样硬化病变中均有较多表达。p2lWaf-1在增殖细胞中表达增强,符合G0-G1过渡。在体内,这种表达主要在新内膜动脉粥样硬化病变中发现。p21Waf-1可能不仅在细胞周期阻滞中起作用,而且在适当的细胞周期进程中起作用。表达p21Waf-1的腺病毒载体诱导SMC细胞周期阻滞和肥大,但不促进细胞再分化和凋亡。综上所述,基质降解是SMC的一个重要功能,并与SMC的表型相协调调节。这些SMC功能可能由内源性和外源性生长因子信号介导。增殖被认为受到细胞周期调节蛋白的严格调控,如p21Waf-1,其功能可能调节SMC表型。这些发现可能有助于理解血管平滑肌细胞的生物学。腺病毒介导的基因转移方法在本项目中使用,可能意味着临床改变人类动脉粥样硬化的治疗意义。少
英文摘要
To understanding the relationship between phenotypic modulation of vascular smooth muscle cells (SMC), and matrix remodeling process, in vitro culture model for the phenotypic modulation of SMC was established. The culture conditions were verified by the alteration of serum-concentration and final cell densities. The expressions of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) were determined with Western blotting and enzyme immunoassays. Collogenolytic activity and gelationolytic activity were also measured. The Expressions and activities of MMP-1, TIMP-1-3, and MMP-1rrIMP-1 expressions were maximal in the cells displaying the proliferative phenotype. MMP-2 expression was not changed with SMC phenotypes. The adenovirus vector expressing TIMP-1 was prepared and the analysis for SMC phenotypes or functions using this vector is addressing.The amount of extra-cellular matrix also regulates SMC phenotypes via the function of cell-cycle regulatory genes. The expression patte … More rn of p2lWaf-1, cyclin-dependent kinase inhibitor was observed in either cultured SMC or human atherosclrotic lesions. p2lWaf-1 expression was enhanced in the proliferating cells in accordance with G0-G1 transition. In vivo, the expression was dominantly detected in neo-intimal atherosclerotic lesions. p21Waf-1 may contribute not only in cell-cycle arrest, but also in an appropriate cell cycle progression. Adenovirus vector expressing p21Waf-1 induced cell cycle arrest and hypertrophy in SMC, but not promoted re-differentiation and apoptosis.In conclusion, Matrix-degradation is an important function of SMC, which is coordinately regulated with SMC phenotypes. These SMC functions may be mediated by both endogenous and exogenous growth factor signalings. Proliferation is considered to be tightly regulated by cell-cycle regulatory proteins, such as p21Waf-1, of which function may modulate SMC phenotypes. These finding may contribute to understanding the biology of vascular smooth muscle cells. The adenovirus-mediated gene transfer method used in this project, may imply clinical alteration of human atherosclerosis in the therapeutic implications. Less
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Seiya Kato, Miki Yamaguchi, Teruhiko Fujii, Naohisa Miyagi, Mizuhiko Terasaki, Tetsuya Hamada, Yasuo Sugita, Minoru Morimatsu: "Over-expression of p21Waf-1 in vascular smooth muscle cells : Regulation oinproliferation, differentiation, and cell size."Exp
Seiya Kato、Miki Yamaguchi、Teruhiko Fujii、Naohisa Miyagi、Mizuhiko Terasaki、Tetsuya Hamada、Yasuo Sugita、Minoru Morimatsu:“血管平滑肌细胞中 p21Waf-1 的过度表达:增殖、分化和细胞大小的调节。”Exp
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seiya Kato他: "Basic fibroblast growth factor regulatea extracellular matrix and contractile protein expression independent of proliferation in vascular smooth muscle cells"In Vitro Cell Dev Biol-Animal. 34. 341-346 (1998)
Seiya Kato 等人:“碱性成纤维细胞生长因子独立于血管平滑肌细胞的增殖调节细胞外基质和收缩蛋白表达”In Vitro Cell Dev Biol-Animal 34. 341-346 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seiya Kato他: "Over-expression of p21 Waf-1 in vascular smooth muscle cells : Regulation in proliferation,differentiation,and cell size." Exp Mol Pathol. (in print).
Seiya Kato 等人:“血管平滑肌细胞中 p21 Waf-1 的过度表达:增殖、分化和细胞大小的调节”(Exp Mol Pathol)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seiya Kato, Hideo Yasukawa, Teruhiko Fujii, Miki Ymaguchi, Naohise, Miyagi, Kenichi Okamoto, Yoshihiro Wada, Morimatsu, Jonathan. C. Fox.: "Coordinate regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression in human
加藤圣哉、安川秀夫、藤井辉彦、山口美纪、尚濑、宫城、冈本健一、和田义弘、森松、乔纳森。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Seiya Kato他: "Corrdinate regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression in vascular smmothe muscle cells."Connect Tissue Res. in print.
Seiya Kato 等人:“血管平滑肌细胞中基质金属蛋白酶-1 和金属蛋白酶-1 组织抑制剂表达的协调调节。”《Connect Tissue Res》印刷版。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
Regulation of vascular smooth muscle phenotypes by lysophosphatidic acid receptor signaling
-
批准号:24590462
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2012
-
负责人:KATO Seiya
-
依托单位:
Influence of depression and mental stress on the experimental atherogenesis in mice
-
批准号:20590404
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:KATO Seiya
-
依托单位:
Development of therapeutics using interleukin-4 (IL-4) mutein in atherosclerotic mouse model showing Th1-dominant immune response
-
批准号:16590328
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.41万
-
财政年份:2004
-
负责人:KATO Seiya
-
依托单位:
Analysis of the Beta2-chimaerin signaling in phenotypiC modulation of vascular smooth muscle cells
-
批准号:13832007
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:KATO Seiya
-
依托单位: